Epoetin alfa prevents, treats chemotherapy-induced anemia

07/19/2013 | MedPage Today (free registration)

Prophylactic epoetin alfa eased anemia during aggressive chemotherapy for breast cancer, a study found. However, 7% of the epoetin alfa-treated patients had thrombotic events, compared with 3% in a control group. "With the exception of this risk, erythropoiesis-stimulating agents appear to be safe drugs for the treatment of chemotherapy-induced anemia or the primary prevention of anemia in patients with intensive dose-dense chemotherapy regimens," according to the report in the Journal of the National Cancer Institute.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA